13F Holdings
中文EN

ITOC iTonic Holdings Ltd Annual reports only

Electromedical & Electrotherapeutic Apparatus · Nasdaq · SEC CIK 1970544

Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY16.7%
TTM net income YoY-671.7%
TTM EPS YoY-511.5%
Revenue 3-yr CAGR-8.4%
Net income 3-yr CAGR—

Margins

Gross margin62.6%
Operating margin-991.7%
Net margin-974.7%
FCF margin-618.6%
EBITDA margin—

Returns

ROE-82.8%
ROA-64.5%
ROIC (approx.)-176.0%
Asset turnover0.07x

Leverage & solvency

Liabilities / assets10.7%
Debt / equity0.00x
Current ratio8.83x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.63x
Accruals ratio-23.6%
Payout ratio—
Capex / revenue0.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31
Income statement
Revenue$523,031$448,196$628,591$679,777
Cost of revenue$195,680$67,041$157,763$121,627
Gross profit$327,351$381,155$470,828$558,150
R&D expense$459,135$93,324$84,474$73,717
SG&A expense$4.87M$750,563$424,899$162,056
Operating income-$5.19M-$770,266-$306,680$27,521
Pretax income-$5.10M-$638,759-$260,508$71,027
Income tax—$21,829-$19,291-$12,953
Net income-$5.10M-$660,588-$241,217$83,980
EPS (basic)-0.32-0.05-0.020.01
EPS (diluted)-0.32-0.05-0.020.01
Weighted avg. shares (diluted)16.04M12.72M12.00M12.00M
Balance sheet
Cash & equivalents$1.49M$6.16M$217,885$72,288
Short-term investments$1.44M———
Receivables$288,456$281,585$206,329—
Inventory$52,479$117,422$52,263—
Current assets$4.09M$6.68M$532,468—
PP&E, net$37,818$45,594$58,885—
Goodwill$1.96M———
Intangibles$2.41M———
Total assets$9.10M$6.72M$1.62M—
Current liabilities$462,817$538,551$1.21M—
Total liabilities$969,832$538,551$1.31M—
Shareholders' equity$6.12M$6.18M$306,272$556,322
Cash flow statement
Operating cash flow-$3.23M-$775,000-$63,636-$116,152
Capital expenditure$3,806$861——
Free cash flow-$3.24M-$775,861——
Investing cash flow-$1.35M-$861——
Financing cash flow-$91,645$6.71M$220,592$78,135
Stock-based compensation$2.95M———
Dividends paid$8,907——$398,444

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.